CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
argenx NV Company Snapshot
argenx NV operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares argenx NV with three other companies in this sector in Belgium: Thrombogenics Nv (2017 sales of 9.06 million Euro [US$11.06 million] ), MDxHealth S.A. (35.56 million Euro [US$43.42 million] ), and Ablynx N.V. (55.53 million Euro [US$67.80 million] of which 100% was Nanobodies).

Sales Analysis. argenx NV reported sales of 36.42 million Euro (US$44.46 million) for the year ending December of 2017. This represents an increase of 147.5% versus 2016, when the company's sales were 14.71 million Euro. Sales at argenx NV have increased during each of the previous five years (and since 2012, sales have increased a total of 2,106%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
argenx NV
  Stock Performance Chart for argenx NV
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 71.50
(Figures in Euro)
1 Week 5.9%   13 Weeks 10.2%  
4 Weeks 35.7%   52 Weeks 333.3%  
 
argenx NV Key Data:
  Ticker: ARGX Country: Netherlands
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 36,415,000
(Year Ending Jan 2018).
Employees: 56
  Currency: Euro Market Cap: 1,921,292,874
  Fiscal Yr Ends: December Shares Outstanding: 26,871,229
  Share Type: Actions Ordinaires Closely Held Shares: 139,823
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.